SCHEMBL3940460

SCHEMBL3940460

CCO[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@@]21C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.73
SMN1; SMN2 Q16637 6/20 0.73
NR3C1 P04150 5/20 0.73
HIF1A Q16665 5/20 0.73
CYP3A4 P08684 5/20 0.73
MEN1 O00255 4/20 0.73
KMT2A Q03164 4/20 0.73
MAPT P10636 4/20 0.73
PGR P06401 4/20 0.73
ADORA3 P0DMS8 3/20 0.73
SLC6A3 Q01959 2/20 0.73
NR1I2 O75469 2/20 0.73
PDE3A Q14432 2/20 0.73
NPSR1 Q6W5P4 2/20 0.73
HPGD P15428 1/20 0.73
MLNR O43193 1/20 0.73
HTT P42858 1/20 0.73
PDE4D Q08499 1/20 0.73
SHBG P04278 5/20 0.68
SERPINA6 P08185 4/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971448 1.00 LMNA (0.73) LMNASMN1; SMN2NR3C1HIF1ACYP3A4
SCHEMBL11408229 0.92 LMNA (0.68) LMNASMN1; SMN2NR3C1HIF1ACYP3A4
SCHEMBL11045530 0.90 LMNA (0.69) LMNASMN1; SMN2NR3C1HIF1ACYP3A4
SCHEMBL8937171 0.90 LMNA (0.72) LMNASMN1; SMN2NR3C1HIF1ACYP3A4
SCHEMBL8853536 0.90 LMNA (0.72) LMNASMN1; SMN2NR3C1HIF1ACYP3A4
SCHEMBL7993191 0.89 LMNA (0.76) LMNASMN1; SMN2NR3C1HIF1ACYP3A4
SCHEMBL11101324 0.89 LMNA (0.71) LMNASMN1; SMN2NR3C1HIF1ACYP3A4
SCHEMBL6801424 0.89 AR (0.82) LMNASMN1; SMN2NR3C1HIF1ACYP3A4
SCHEMBL260024 0.88 SMN1; SMN2 (0.74) LMNASMN1; SMN2NR3C1HIF1ACYP3A4
SCHEMBL13941349 0.88 SMN1; SMN2 (0.74) LMNASMN1; SMN2NR3C1HIF1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976997-B1 PROCESS FOR THE PREPARATION OF 11BETA-HYDR0XY-9BETA,10ALPHA-STEROIDS EMPLOYING AMYCOLATOPSIS MEDITERRANEI CELLS SOLVAY PHARM GMBH (DE) 2009-04-08 EP disclosed
EP-1976997-A1 PROCESS FOR THE PREPARATION OF 11BETA-HYDR0XY-9BETA, 10ALPHA -STEROIDS EMPLOYING AMYCOLATOPSIS MEDITERRANEI CELLS Solvay Pharmaceuticals GmbH (DE) 2008-10-08 EP disclosed
US-20070212751-A1 Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriods SOLVAY PHARMACEUTICALS GMBH (DE) 2007-09-13 US disclosed
WO-2007082891-A1 PROCESS FOR THE PREPARATION OF 11BETA-HYDR0XY-9BETA, 10ALPHA -STEROIDS EMPLOYING AMYCOLATOPSIS MEDITERRANEI CELLS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-07-26 WO disclosed